<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/429BC940-A5EA-42AF-B76A-ECE3FD9E59A1"><gtr:id>429BC940-A5EA-42AF-B76A-ECE3FD9E59A1</gtr:id><gtr:name>Experimental Zooprophilactic Institute of Campania and Calabria  Italy</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A0397DD-E0C6-4EA3-8031-B841D2503C4D"><gtr:id>7A0397DD-E0C6-4EA3-8031-B841D2503C4D</gtr:id><gtr:name>Royal Holloway, University of London</gtr:name><gtr:address><gtr:line1>Egham Hill</gtr:line1><gtr:line4>Egham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>TW20 0EX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D8FC3D7B-4875-400D-9DA8-560B39177BF1"><gtr:id>D8FC3D7B-4875-400D-9DA8-560B39177BF1</gtr:id><gtr:name>PTC - Phage Technology Center GmbH</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Biosciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/429BC940-A5EA-42AF-B76A-ECE3FD9E59A1"><gtr:id>429BC940-A5EA-42AF-B76A-ECE3FD9E59A1</gtr:id><gtr:name>Experimental Zooprophilactic Institute of Campania and Calabria  Italy</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A0397DD-E0C6-4EA3-8031-B841D2503C4D"><gtr:id>7A0397DD-E0C6-4EA3-8031-B841D2503C4D</gtr:id><gtr:name>Royal Holloway, University of London</gtr:name><gtr:address><gtr:line1>Egham Hill</gtr:line1><gtr:line4>Egham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>TW20 0EX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D8FC3D7B-4875-400D-9DA8-560B39177BF1"><gtr:id>D8FC3D7B-4875-400D-9DA8-560B39177BF1</gtr:id><gtr:name>PTC - Phage Technology Center GmbH</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AB4E779C-778F-4E10-9EDD-1DAFA875A5E6"><gtr:id>AB4E779C-778F-4E10-9EDD-1DAFA875A5E6</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Connerton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI024682%2F1"><gtr:id>634036EB-C2DE-4215-A06D-32E5378A40C7</gtr:id><gtr:title>Predictive modelling to optimise phage intervention against Campylobacter in poultry</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I024682/1</gtr:grantReference><gtr:abstractText>Campylobacter jejuni and C. coli are bacteria that cause are human food-borne infections through out the world. In common with other European countries, campylobacters are the most commonly recorded cause of acute bacterial enteritis in the UK with 57,772 cases of campylobacteriosis reported to the Health Protection Agency in 2009. However, due to under-reporting the true incidence could be 8-fold higher with estimated costs to the UK economy approaching &amp;pound;600 million per annum. Birds in general naturally carry the bacteria but it is poultry that act as a major vehicle for the infection of the humans through undercooked meat or cross-contamination of other foods in the kitchen. This project will investigate use bacteriophage as a sustainable form of biocontrol against Camplyobacter colonizing and contaminating poultry and poultry meat. Bacteriophage, often simply called phage, are viruses that kill bacteria. Phage are quite specific, they will only affect the target bacteria and not other bacterial flora. They are also common in the environment such that all people encounter them on a daily basis, which includes their presence on fresh produce. The application of phages to kill campylobacters on chickens therefore represents a natural and sustainable measure to reduce the numbers of the pathogen entering the food chain from this source. The optimal use of phage therapy will require good understanding of phage-Campylobacter interactions at all stages of poultry farming and processing. This proposal will build a comprehensive understanding of Campylobacter-bacteriophage interactions in poultry from colonization of the birds to presentation of the meat at retail. It will combine laboratory work and predictive modelling to design protocols for optimal practical phage therapy.</gtr:abstractText><gtr:technicalSummary>The use of bacteriophage targeted against Camplyobacter infection in poultry is a potentially powerful form of biocontrol. Optimal use of phage therapy will require good understanding of phage-Campylobacter interactions at all stages of poultry farming and processing. This proposal will build a uniquely comprehensive understanding of Campylobacter-bacteriophage interactions in poultry from infection to carcass. It will combine laboratory interventions and predictive modelling in three strands. We will: 1. Build a comprehensive understanding of in vivo phage-Campylobacter kinetics in broiler chickens. 2. Determine how post-slaughter kinetics contributes to phage therapy efficacy. 3. Use our predictive models to design protocols for optimal practical phage therapy.</gtr:technicalSummary><gtr:potentialImpactText>The current proposal is in response to the BBSRC, Defra and FSA research call in support of policy makers and industry to achieve a reduction in the levels of Campylobacter entering the food chain and thereby the incidence of foodborne Campylobacter enteritis in the UK population. Campylobacters are the most commonly recorded cause of acute bacterial enteritis in the UK with an estimated cost approaching &amp;pound;600 million per annum to the economy. Poultry are a major source of infection and this proposal represents a sustainable intervention to reduce the levels of Campylobacter in broiler chickens and on chicken meat. Potential Beneficiaries 1. The public will benefit through a reduction in the incidence of campylobacteriosis, and therefore reduced morbidity, general improved health and no loss of earnings through illness. 2. Policymakers will benefit on completion of the project by gaining an understanding of how phage therapy can be applied, any constraints on efficacy and how these may relate regulatory issues that are currently in focus with an increasing number of permissions being sought for the application of phage for therapeutic and biosanitization purposes in agriculture and on ready to eat foods. 3. The poultry industry will benefit through the provision of a sustainable intervention against Campylobacter in poultry 4. Agri-food and healthcare industries in general may benefit on completion of the project through the provision of quantitative mathematical models that will predict the phamakinetics of phage in an intestinal environment and beyond 5. The food industry in general will benefit in the long term through increased consumer confidence if the levels of foodborne illness decline</gtr:potentialImpactText><gtr:fund><gtr:end>2015-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>400250</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Holloway, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Quantitative modelling of phage therapy</gtr:description><gtr:id>220B8B3C-5BE8-46D1-9903-2ACFBA45C385</gtr:id><gtr:outcomeId>b95fc1b6b95fc1d4-1</gtr:outcomeId><gtr:piContribution>Research collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PTC - Phage Technology Center GmbH</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Use of bacteriophage in prepared foods</gtr:description><gtr:id>88814BD9-D0B0-4533-9AA7-0864EB2058D7</gtr:id><gtr:impact>Phages 2015: Bacteriophage in Medicine, Food and Biotechnology
01-02 September 2015 St Hilda's College, Oxford, UK
Investigation of structures influencing bacteriophage infection of Campylobacter jejuni
Lukas Lis1, and Ian F Connerton2
1PTC Phage Technology Center GmbH, Im Kompetenzzentrum BioSecurity, B&amp;ouml;nen, Germany
2Division of Food Sciences, School of Biosciences, University of Nottingham, Loughborough, Leicestershire, UK</gtr:impact><gtr:outcomeId>56b0bc561da2a8.17048106-1</gtr:outcomeId><gtr:partnerContribution>Performing experimental trials. Scale-up of phage production.</gtr:partnerContribution><gtr:piContribution>Design of experimental trials. Phage discovery and molecular characterisation.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Experimental Zooprophilactic Institute of Campania and Calabria  Italy</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Bacteriophage applications in food safety</gtr:description><gtr:id>AFBE6850-8B2D-4BD7-AF91-FC49ED5893B0</gtr:id><gtr:impact>Multi-disciplinary: Microbiology, Quantitative modelling, Veterinary Sciences, Public Health</gtr:impact><gtr:outcomeId>56d59ee751ac61.38705060-1</gtr:outcomeId><gtr:partnerContribution>Animal trial facilities</gtr:partnerContribution><gtr:piContribution>Development of methods for application and scale up</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public lecture Nottingham: Bacteriophage Control of Bacterial Pathogens: My enemy's enemy is my friend?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AD862088-9559-4EBF-BB99-96CF188A8585</gtr:id><gtr:impact>Public interest in phage therapy against antibiotic resistant bacteria.

On-line discussions</gtr:impact><gtr:outcomeId>542eaf09c1f6b5.56310971</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CHRO 2013: A real time model of in-vivo Campylobacter populations within chicken caeca: applications for bacteriophage host dynamics</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8E2171D5-51AB-4B03-948C-6BAFCC1B6227</gtr:id><gtr:impact>Stimulated interest in research activity.

Limiting the number of parameters and animals in enteric experiments.</gtr:impact><gtr:outcomeId>5447c8a322a224.71515145</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science with Impact - Annual Conference 2015 BSAS &amp; WPSA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>34AFF8EE-6DCF-4DF4-BF6F-8F603A99D47D</gtr:id><gtr:impact>Discussion between a mixed industry and academic audience.

To be confirmed.</gtr:impact><gtr:outcomeId>54d219da02b437.89727920</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bsas.org.uk/events-conferences/annual-conference-2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe Scientifique Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EC3CED3D-25AC-4D9D-A1BA-682F07323093</gtr:id><gtr:impact>Wide ranging discussion.

Interest in responses antibiotic resistance from public audience.</gtr:impact><gtr:outcomeId>54d21bf3118285.07848416</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.meetup.com/nottingham-culture-cafe-sci/events/calendar/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Campylobacter workshop 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7C9AC549-8A1F-411B-89E0-48F1AB2D7499</gtr:id><gtr:impact>Discussion with international representatives.

Collaboration</gtr:impact><gtr:outcomeId>542eb5f79fbc72.86988126</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Bacterial infections of man and animals impact directly on human health and food quality. The rise in antibiotic resistance has adversely impacted on our ability to treat these infections. Bacteriophage are naturally occurring viruses that specifically kill target bacteria, and have the potential to be used for therapeutic and food disinfection purposes. We have developed models and application parameters that will assist in the practical application of bacteriophage.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>1DC3272D-D5B0-4F94-B798-15958E31B9B0</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5447d69252c412.60634825</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Campylobacter jejuni and C. coli are bacteria that cause are human food-borne infections throughout the world. Poultry are a major source of infection through undercooked meat or cross-contamination of other foods in the kitchen. We have found ways of delivering naturally occurring viruses that specifically kill the bacteria and only the target bacteria, in poultry and on poultry meat.</gtr:description><gtr:exploitationPathways>Commercial companies are using the models and developing delivery protocols for bacteriophage on poultry meat in non-EU countries.</gtr:exploitationPathways><gtr:id>50AECED4-64F9-458A-847A-DC9BA0BC652E</gtr:id><gtr:outcomeId>5447d05b6fdb63.70683848</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Environment,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Complete DNA sequnence of the Eucampyviriae used in phage therapy applications. NCBI GenBank</gtr:description><gtr:id>A0EEC2A6-CBE0-40B2-9602-5AAB14CF6FFB</gtr:id><gtr:impact>No actual impacts realised to date</gtr:impact><gtr:outcomeId>r-7346717414.7690866d77b82</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Campylobacter phage CP8, complete genome</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Recombination and diversity amongst Campylobacter bacteriophage in chickens. GenBank</gtr:description><gtr:id>E7718854-53E0-4B09-842B-10E6BD6B8F67</gtr:id><gtr:impact>No actual impacts realised to date</gtr:impact><gtr:outcomeId>r-505829658.830379866d7e4a0</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Campylobacter phage CP30A, complete genome.</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Genome sequence of universal bacteriophage host strain Campylobacter jejuni subspecies jejuni PT14</gtr:description><gtr:id>32510CCC-E150-4338-BA58-86F95A6EC8D4</gtr:id><gtr:impact>No actual impacts realised to date</gtr:impact><gtr:outcomeId>r-8997533590.53054266d79342</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Campylobacter jejuni subsp. jejuni PT14, complete genome.</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EF1C6E82-FE59-44F9-87E3-C586D618DFA9</gtr:id><gtr:title>Pilot study of long-term anaesthesia in broiler chickens.</gtr:title><gtr:parentPublicationTitle>Veterinary anaesthesia and analgesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/500f3ad62107ea8ab6e95098afefc0fa"><gtr:id>500f3ad62107ea8ab6e95098afefc0fa</gtr:id><gtr:otherNames>O'Kane PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1467-2987</gtr:issn><gtr:outcomeId>561b73c1ca4757.13221849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFD3A589-69ED-4F4F-B487-6E908C414B9F</gtr:id><gtr:title>Host adaption to the bacteriophage carrier state of Campylobacter jejuni.</gtr:title><gtr:parentPublicationTitle>Research in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3255e80d4c5be2f67ac41fcf568604cc"><gtr:id>3255e80d4c5be2f67ac41fcf568604cc</gtr:id><gtr:otherNames>Brathwaite KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0923-2508</gtr:issn><gtr:outcomeId>5567029d983348.65770141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C1804AA-15F5-4FDB-A71A-0D0D43562337</gtr:id><gtr:title>The evolution of sex-specific virulence in infectious diseases.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75c254e477cd2cbc2a939b9ac46fc84f"><gtr:id>75c254e477cd2cbc2a939b9ac46fc84f</gtr:id><gtr:otherNames>?beda F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58a2fcb82a9e33.94838884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0655410F-1F2B-4F9B-827B-5C796ED97664</gtr:id><gtr:title>Siderophore production and the evolution of investment in a public good: An adaptive dynamics approach to kin selection.</gtr:title><gtr:parentPublicationTitle>Journal of theoretical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c4a2006526563a3292a0a2a3291cd3"><gtr:id>34c4a2006526563a3292a0a2a3291cd3</gtr:id><gtr:otherNames>Lee W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-5193</gtr:issn><gtr:outcomeId>56b4731b8d5083.26364642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4529F2A-44D9-4B82-AD5D-7919840BC3C3</gtr:id><gtr:title>Campylobacters and their bacteriophages from chicken liver: The prospect for phage biocontrol.</gtr:title><gtr:parentPublicationTitle>International journal of food microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60349fc9dd574e4c99cee48436fa0d26"><gtr:id>60349fc9dd574e4c99cee48436fa0d26</gtr:id><gtr:otherNames>Firlieyanti AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-1605</gtr:issn><gtr:outcomeId>5807990fbfa821.77357508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B5EF381-4F70-4737-9078-D71A8C27F432</gtr:id><gtr:title>Bacteriophages: Nature's control of bacterial populations</gtr:title><gtr:parentPublicationTitle>Food Science and Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcfc8d7dcc3a15af94a687100e6a0a19"><gtr:id>dcfc8d7dcc3a15af94a687100e6a0a19</gtr:id><gtr:otherNames>Timms A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>5893462c901fc0.78604089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3E25131-09FD-4439-AA5E-3EEE1E0B7E63</gtr:id><gtr:title>The Minor Flagellin of(FlaB) Confers Defensive Properties against Bacteriophage Infection.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5fbeff3072d3abf55e79c793ea203b1"><gtr:id>b5fbeff3072d3abf55e79c793ea203b1</gtr:id><gtr:otherNames>Lis L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5893355cb0dac6.46401307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FB71D48-618D-467F-996D-30B0B6EFE755</gtr:id><gtr:title>Phase variation of a Type IIG restriction-modification enzyme alters site-specific methylation patterns and gene expression in Campylobacter jejuni strain NCTC11168.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc1475612432fbcf626b4c0f0d05a985"><gtr:id>bc1475612432fbcf626b4c0f0d05a985</gtr:id><gtr:otherNames>Anjum A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56b0a7dc9a4d03.84749910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36B4078D-1B83-41A7-AAF9-C7C0C457F02D</gtr:id><gtr:title>Campylobacter bacteriophages and bacteriophage therapy.</gtr:title><gtr:parentPublicationTitle>Journal of applied microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30b62e4468b46d24d433f799125f4389"><gtr:id>30b62e4468b46d24d433f799125f4389</gtr:id><gtr:otherNames>Connerton PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1364-5072</gtr:issn><gtr:outcomeId>542d8790aea2e2.69727151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9795CD58-4E0D-4F06-A816-2A995CB11864</gtr:id><gtr:title>Complete Genome Sequence of Universal Bacteriophage Host Strain Campylobacter jejuni subsp. jejuni PT14.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3255e80d4c5be2f67ac41fcf568604cc"><gtr:id>3255e80d4c5be2f67ac41fcf568604cc</gtr:id><gtr:otherNames>Brathwaite KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>542d887e7cf1f4.64957594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C842E2-9686-4A5E-B8AA-C9F34B02B2D0</gtr:id><gtr:title>Campylobacter jejuni acquire new host-derived CRISPR spacers when in association with bacteriophages harboring a CRISPR-like Cas4 protein.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/054431146b61742777ee0519bf8372e0"><gtr:id>054431146b61742777ee0519bf8372e0</gtr:id><gtr:otherNames>Hooton SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5893462ba38549.33172067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD4C2C73-FC71-4CC3-90F9-CB86606210E7</gtr:id><gtr:title>The Bacteriophage Carrier State of Campylobacter jejuni Features Changes in Host Non-coding RNAs and the Acquisition of New Host-derived CRISPR Spacer Sequences.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/054431146b61742777ee0519bf8372e0"><gtr:id>054431146b61742777ee0519bf8372e0</gtr:id><gtr:otherNames>Hooton SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>580799e65c68e2.96194317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F2DCAB-3E46-447C-8AAE-3A33632666B7</gtr:id><gtr:title>Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/261f74685fbd8984e98d345ec401ec59"><gtr:id>261f74685fbd8984e98d345ec401ec59</gtr:id><gtr:otherNames>Siringan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>542d8790e8ed19.31215541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE6E09FC-FB76-40D9-9553-F8DA816F06F2</gtr:id><gtr:title>Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/261f74685fbd8984e98d345ec401ec59"><gtr:id>261f74685fbd8984e98d345ec401ec59</gtr:id><gtr:otherNames>Siringan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>542d887e4e8804.10183179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4325C65-590C-4F81-9693-A782E3F26438</gtr:id><gtr:title>A suggested new bacteriophage genus: &amp;quot;Viunalikevirus&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Archives of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e928713be885315c6884b5263555eac"><gtr:id>0e928713be885315c6884b5263555eac</gtr:id><gtr:otherNames>Adriaenssens EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0304-8608</gtr:issn><gtr:outcomeId>5893462c50ebb8.86999887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D62D76D-2673-497E-97EC-D10ECB0B9381</gtr:id><gtr:title>A suggested classification for two groups of Campylobacter myoviruses.</gtr:title><gtr:parentPublicationTitle>Archives of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79415790c2f1a48861acb2368ed77e87"><gtr:id>79415790c2f1a48861acb2368ed77e87</gtr:id><gtr:otherNames>Javed MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0304-8608</gtr:issn><gtr:outcomeId>542d887feb3732.23756574</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I024682/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>